Ultrasound Imaging in Active Surveillance of Small, Low-Risk Papillary Thyroid Cancer.
Sangeet GhaiDavid Paul GoldsteinAnna M SawkaPublished in: Korean journal of radiology (2024)
The recent surge in the incidence of small papillary thyroid cancers (PTCs) has been linked to the widespread use of ultrasonography, thereby prompting concerns regarding overdiagnosis. Active surveillance (AS) has emerged as a less invasive alternative management strategy for low-risk PTCs, especially for PTCs measuring ≤1 cm in maximal diameter. Recent studies report low disease progression rates of low-risk PTCs ≤1 cm under AS. Ongoing research is currently exploring the feasibility of AS for larger PTCs (<20 mm). AS protocols include meticulous ultrasound assessment, emphasis on standardized techniques, and a multidisciplinary approach; they involve monitoring the nodules for size, growth, potential extrathyroidal extension, proximity to the trachea and recurrent laryngeal nerve, and potential cervical nodal metastases. The criteria for progression, often defined as an increase in the maximum diameter of the PTC, warrant a review of precision and ongoing examinations. Challenges exist regarding the reliability of volume measurements for defining PTC disease progression. Although ultrasonography plays a pivotal role, challenges in assessing progression and minor extrathyroidal extension underscore the importance of a multidisciplinary approach in disease management. This comprehensive overview highlights the evolving landscape of AS for PTCs, emphasizing the need for standardized protocols, meticulous assessments, and ongoing research to inform decision-making.
Keyphrases
- papillary thyroid
- lymph node metastasis
- magnetic resonance imaging
- decision making
- contrast enhanced
- optic nerve
- squamous cell carcinoma
- lymph node
- human health
- heart rate
- risk factors
- single cell
- neoadjuvant chemotherapy
- risk assessment
- radiation therapy
- body composition
- ultrasound guided
- young adults
- rectal cancer
- childhood cancer